A possible mechanism for increased breast cell proliferation by progestins through increased reductive 17β‐hydroxysteroid dehydrogenase activity
Authors:
- 15 January 1990
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 45 (1) , 174-178
Abstract
We have investigated whether progestins may be able to regulate breast cell proliferation by altering the fraction of oestradiol relative to oestrone, using the human breast cancer cell line MCF-7. The ability of the two oestrogens, oestradiol and oestrone, to stimulate breast tumour cell proliferation was investigated. Oestradiol in concentration was of 10-fold greater proliferative potency than oestrone. The progestin MPA increased both reductive and oxidative 17β-hydroxysteroid oxidoreductase activity when the tissue culture media pH indicator phenol red was included in the media. When phenol red was excluded from the tissue culture media, MPA increased predominantly the reductive 17β-hydroxysteroid oxidoreductase activity, and to a far greater extent than in the presence of phenol red. Other progestins such as levonorgestrel, norethisterone and norethisterone acetate also increased predominantly reductive 17β-hydroxysteroid oxidoreductase activity in the absence of phenol red. The action of MPA on reductive 17β-hydroxysteroid oxidoreductase activity was increased by treatment with oestradiol to a small but significant extent. We propose that the progestational increase of reductive 17β-hydroxysteroid oxidoreductase activity is a possible mechanism by which progestins may increase breast cell proliferation in vivo.Keywords
This publication has 28 references indexed in Scilit:
- Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cellsBreast Cancer Research and Treatment, 1989
- Comment on ‘Difference between R5020 and the anti progestin RU486 in antiproliferative effects on human breast cancer cells’Breast Cancer Research and Treatment, 1988
- Lipophilic impurities, not phenolsulfonphthalein, account for the estrogenic activity in commercial preparations of phenol redThe Journal of Steroid Biochemistry and Molecular Biology, 1988
- Estrogen and antiestrogen interaction with estrogen receptor of MCF-7 cells—Relationship between processing and estrogenicityThe Journal of Steroid Biochemistry and Molecular Biology, 1988
- Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) cultureEuropean Journal of Cancer and Clinical Oncology, 1987
- Estrogenic effect of phenol red in MCF-7 cells is achieved through activation of estrogen receptor by interacting with a site distinct from the steroid binding siteBiochemical and Biophysical Research Communications, 1987
- Immunological detection and quantitation of alpha transforming growth factors in human breast carcinoma cellsBreast Cancer Research and Treatment, 1986
- Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal womenEuropean Journal of Cancer and Clinical Oncology, 1986
- Oral high-dose medroxyprogesterone acetate (MAP) in treatment of advanced breast cancerBreast Cancer Research and Treatment, 1981
- The role of estradiol dehydrogenase in mediating progestin effects on endometrium from postmenopausal women receiving estrogens and progestinsThe Journal of Steroid Biochemistry and Molecular Biology, 1981